Lee’s Pharmaceutical Announces Land Resumption Agreement

Lee’s Pharmaceutical Holdings Limited (HK:0950) has released an update.

Lee’s Pharmaceutical Holdings Limited has announced a land resumption agreement involving its subsidiary, Guangzhou Zhaokang Hospital Company, due to national construction needs in Guangzhou, China. The company will receive compensation totaling RMB89.2 million, with an initial payment of RMB10 million followed by the remainder after the land’s potential disposal. This move could impact the company’s future operations and financial standing, drawing attention from investors and market analysts.

For further insights into HK:0950 stock, check out TipRanks’ Stock Analysis page.